News

Dermatologists in New Zealand have highlighted a significant gap in the treatment of eczema, with many patients unable to access...

After a decade of dedicated research, the "Skin Twins" are introducing an exclusive survey aimed at enhancing understanding of skin...

A recent study published in Skin Health and Disease reveals that just over a quarter of dermatologists in Hungary (25.5%)...

Experts are advocating for increased assistance for New Zealanders aged 65 and older, who face heightened risks associated with shingles,...

A recent survey has shed light on the profound impact of eczema on New Zealanders, revealing a relentless pursuit for...

In the midst of Gaza's ongoing humanitarian crisis, children are facing a new threat: rampant skin diseases. Wafaa Elwan, a...

The US Food and Drug Administration (FDA) has approved Pyzchiva (ustekinumab-ttwe), a biosimilar developed by Samsung Bioepis Co., Ltd., for...

Almirall's Ilumetri (tildrakizumab) has shown promising results in restoring the well-being of patients with moderate to severe plaque psoriasis to...

Psoriasis is linked to fatigue, particularly among individuals with psoriatic arthritis (PsA), according to a recent study published in the...

A recent study published in ACR Open Rheumatology reveals that individuals diagnosed with psoriasis (PsO) at age 43 or older...